News: BDA BOD Australia secures binding letter of intent with a Swiss manufacturer, page-147

I am bewildered by MMJ, MDC, MXC market caps....its the BOTs, BDAs, ESEs and CPHs that are innovative, have higher margins, higher growth and its biopharmas going somewhere. The growers are basically a waste of time. Government and license constrained per country, heavy regulation and penetration.....

Search engines did well in internet 1.0 and basically no one survived.....The innovators always winout for Mark 2......Google, facebook, Amazon, Ebay.... or even tesla....Innovation and penetration always wins.

The Cannabanoids, synthetics will kill it in disease management, dermatology sectors....Biopharm is going to be massive. Multi Billion dollar industry growing. BDA and Linnea/Ipsen/Schwabe.de is one hell of a European/Pan Asian partnership......

The grower dependents should be at a discount to the innovating biopharm like BDA.

Very big days ahead. Plenty of catchup to come. Im expecting a breakout day any day now.


GG